Clinical AI Has an Evidence Problem, and It Is Economic

A persistent fallacy in clinical AI is that regulatory approval and high diagnostic accuracy are the finish lines. Teams celebrate when their model achieves parity with human specialists and secures an FDA clearance or CE mark. Yet, these models routinely stall before deployment. The friction is not clinical validity; it is the health-economic case. Accuracy and approval do not automatically produce adoption because hospital systems do not buy algorithmic performance, they buy outcomes that survive budgetary constraints.

Key takeaways

• The bottleneck has moved: Clinical AI is no longer bottlenecked by data science or regulatory clearance; the primary barrier to adoption is now health economics and workflow integration.
• Accuracy is just the baseline: High diagnostic accuracy gets a model into the conversation, but transparent economic evaluations are what secure hospital budgets.
• Usability is an economic variable: Poor interface design in complex workflows (like NGS) creates cognitive load and time penalties, which directly destroy the economic case for adoption.
• Transparency is now standardized: The CHEERS-AI standard forces vendors to detail the hidden costs of AI, from staff training and integration to the model’s learning curve over time.

The Shift from Data Science to Health Economics

For years, the development of clinical AI focused almost exclusively on improving diagnostic accuracy and securing regulatory approval. This created a generation of algorithms that perform exceptionally well in controlled environments but fail to scale in the real world. The bottleneck in clinical AI has shifted from data science to health economics. The Consolidated Health Economic Evaluation Reporting Standards for Interventions that use AI (CHEERS-AI) was introduced to ensure evaluations are reported transparently to support interpretation and comparison, as pilot exercises showed that important AI-specific details are frequently missing or inadequately reported.

Hospital procurement teams are increasingly skeptical of vendor claims regarding cost savings. When a vendor claims an AI intervention saves money, the underlying assumptions, such as the true cost of integration, the model’s learning curve, and the software’s maintenance overhead, are often opaque. CHEERS-AI forces a new standard of transparency, demanding that researchers detail the mechanism by which the intervention affects care pathways, costs, and health outcomes. Without this transparency, hospital systems cannot accurately assess the return on investment for deploying an AI tool, leading to stalled pilot programs and abandoned initiatives.

Why Transparency Fails in Practice

The CHEERS-AI framework is rigorous, demanding that developers provide detailed reporting on the model’s structure, the source data, and the sociotechnical context of deployment. However, the reality of clinical IT procurement means that these standards are often treated as compliance checkboxes rather than strategic planning tools. A hospital may demand to see a model’s cost-effectiveness analysis, but if that analysis assumes a frictionless integration into the electronic health record (EHR) system, an assumption that is almost universally false, the economic projections will collapse within the first month of pilot testing.

This disconnect between theoretical cost savings and practical implementation creates a credibility gap. Developers must recognize that the burden of proof is shifting. It is no longer sufficient to show that an AI tool could save money in a perfectly optimized workflow. Vendors must demonstrate that their tool will save money within the messy, fragmented, and legacy-bound reality of modern hospital IT infrastructure.

The Hidden Costs of Workflow Integration

The most significant of these hidden costs is rarely the software license itself; it is the sociotechnical cost of workflow integration. A model that requires a clinician to switch between multiple interfaces or manually input data introduces friction that can negate any theoretical efficiency gains. Research into AI-powered next-generation sequencing (NGS) workflows demonstrates that the transition of AI-driven tools into clinical practice is hindered by fragmented workflows, limited usability, and non-standardized data interfaces.

These integration challenges are particularly acute in specialized fields like genomics, where the volume of data is immense and the clinical decisions are highly consequential. When complex analytical pipelines fail to simplify into transparent, interactive systems, poor usability leads to underutilization, misinterpretation, or outright rejection. A model’s theoretical value is constrained by its usability. If a clinician cannot quickly and confidently interpret the AI’s output, they will revert to traditional methods, rendering the investment useless.

The NGS study underscores this by highlighting that the cognitive load on clinical staff is often ignored during the procurement process. When an AI tool forces a geneticist or pathologist to constantly switch context, re-enter data, or parse opaque algorithmic confidence scores, the time penalty accrues rapidly. If an AI tool saves ten minutes of diagnostic time but requires fifteen minutes of manual data wrangling to operate, the health-economic case is destroyed.

The researchers mapped where AI actually touches a sequencing workflow, and the answer is scattered across four roles and five stages rather than concentrated in the model.

Exhibit 1. Data requirements for AI in a next-generation sequencing workflow, mapped across four clinical roles and five workflow stages. Source: Plass, M., Holzinger, A., Reihs, R., & Müller, H., 2026, Integrating AI into clinical practice: Human-centered design requirements for next-generation sequencing workflows, Computerized Medical Imaging and Graphics, 130, 102758, p. 6.

Usability as a Core Economic Variable

As we have seen in the transformation of healthcare services with AI ecosystems, integrating these tools requires treating usability as a core economic variable. Poor human-computer interaction is not just an interface problem; it is a systemic workflow failure that incurs measurable financial penalties. Every extra click, every confusing visualization, and every disjointed workflow step adds to the cognitive load of the clinician and the operational cost of the hospital.

Designing for this reality means recognizing that requirements engineering for probabilistic software is entirely different from traditional IT procurement. Standard software provides deterministic outputs based on fixed rules; AI models provide probabilistic predictions that require human interpretation and oversight. The interface must be designed to support this nuanced interaction, providing clear explanations of the model’s confidence and reasoning.

Crossing the Chasm to Deployment

To cross the chasm from an approved algorithm to a deployed standard of care, clinical AI must prove its value through rigorous, standardized economic evaluation. The CHEERS-AI framework provides a roadmap for this evaluation, highlighting the need to account for AI-specific costs and operational impacts. Developers must move beyond demonstrating clinical equivalence and start demonstrating economic superiority in real-world settings.

Accuracy gets a model into the conversation. Workflow integration and hard economic evidence are what keep it in the hospital. The future of clinical AI will be defined not by the models with the highest area under the curve, but by the models that seamlessly integrate into clinical workflows and deliver clear, quantifiable economic value.

References

• Elvidge, J., Hawksworth, C., Avşar, T. S., Zemplenyi, A., Chalkidou, A., Petrou, S…. & Dawoud, D. (2024). Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI). Value in Health, 27(9), 1196-1205. https://doi.org/10.1016/j.jval.2024.05.006
• Plass, M., Holzinger, A., Reihs, R., & Müller, H. (2026). Integrating AI into clinical practice: Human-centered design requirements for next-generation sequencing workflows. Computerized Medical Imaging and Graphics, 130, 102758. https://doi.org/10.1016/j.compmedimag.2026.102758